Pricing Log in Create free account

Alumis Inc. (ALMS) vs Inventiva S.A. Sponsored ADR (IVA)

Alumis Inc. and Inventiva S.A. Sponsored ADR are both Biotechnology companies. Inventiva S.A. Sponsored ADR is the larger, with a market value of $944.5M against $854.4M — 1.1× the size. Inventiva S.A. Sponsored ADR has the higher net margin (−750.3% vs −5,933.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Inventiva S.A. Sponsored ADR leads on 8 and Alumis Inc. on 7.

Valuation

Metric ALMS IVA Biotechnology median
P/E n/m n/m 10.96
P/S 110.64 7.80 9.52
P/B 1.81 2.23 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 0.68
EV/Sales 42.74 1.91 9.00
Earnings yield (59.17%) (89.97%) (32.09%)
Free cash flow yield (42.98%) (89.80%) (22.62%)

Profitability

Metric ALMS IVA Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (6,204.39%) 0.00% 0.00%
Net margin (5,933.45%) (750.28%) 0.00%
Free cash flow margin (4,755.33%) 0.00% 0.00%
Return on equity (93.65%) 0.00% (50.12%)
Return on assets (74.94%) 0.00% (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALMS IVA Biotechnology median
Revenue growth (TTM) — 547.89% 6.78%
EPS growth (last fiscal year) 72.45% 35.44% 29.88%
Revenue growth, 5-year CAGR — 8.33% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ALMS IVA Biotechnology median
Debt to equity 0.00 1.13 0.00
Current ratio 6.74 3.81 4.74
Net debt to EBITDA 0.69 0.29 1.01

Dividend

Metric ALMS IVA Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric ALMS IVA Biotechnology median
Market cap 854.37m 944.45m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack